Publications by the researcher in collaboration with Maria Del Carmen Asensio Lopez (30)

2023

  1. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 704-720

2022

  1. Critical warm ischemia time point for cardiac donation after circulatory death

    American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328

2021

  1. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction

    Journal of the American College of Cardiology, Vol. 77, Núm. 14, pp. 1747-1759

  2. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)

    Scientific Reports

  2. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure

    Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 315-319

  2. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction

    Diabetes and Metabolism

  3. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure

    Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025

  4. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2018

  1. Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction

    Journal of the American College of Cardiology

  2. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction

    Translational Research, Vol. 199, pp. 4-23

  3. Pulmonary Production of Soluble ST2 in Heart Failure

    Circulation. Heart failure, Vol. 11, Núm. 12, pp. e005488

  4. Short-term Serial Measurement of Galectin-3 in Hospitalized Patients With Acute Heart Failure

    Revista Espanola de Cardiologia, Vol. 71, Núm. 5, pp. 401-402

2017

  1. Concentración de relaxina en pacientes con insuficiencia cardiaca aguda. Respuesta

    Revista Espanola de Cardiologia

  2. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes

    PLoS ONE, Vol. 12, Núm. 2

  3. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 10, Núm. 5-6, pp. 460-469

2016

  1. Ausencia de implicación de la cistatina C en el remodelado ventricular y la insuficiencia cardiaca

    Revista Clinica Espanola, Vol. 216, Núm. 2, pp. 55-61

  2. Clinical relevance of sST2 in cardiac diseases

    Clinical Chemistry and Laboratory Medicine, Vol. 54, Núm. 1, pp. 29-35

  3. Concentración de relaxina en pacientes con insuficiencia cardiaca aguda: comportamiento y determinantes clínicos

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1230-1232